台股 » 個股 » 國邑* » 籌碼相關 » 券商分點績效

國邑*

(6875)
  • 股價
    51.4
  • 漲跌
    ▼1.6
  • 漲幅
    -3.02%
  • 成交量
    111
  • 產業
    上櫃 生技醫療類股
  • 8人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
國邑* (6875)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2025/03/28     後一日»

券商獲利排行 - 2025/03/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.33%10.4010.4-1501552.1052.151.4
  1.25%10.4010.4-1601652.1052.151.4
  1.15%4.204.2-7075205251.4
  0.55%3.103.1-1101151.7051.751.4
  1.15%303-5055205251.4
  2.10%2.202.2-20252.5052.551.4
  0.96%202-40451.9051.951.4
  0.18%202-2202251.5051.551.4
  1.15%1.801.8-2035251.95251.4
  1.15%1.201.2-2025205251.4
  1.53%0.800.8-10152.2052.251.4
  0.19%0.600.666051.351.3051.4
  1.15%0.600.6-1015205251.4
  0.77%0.400.4-10151.8051.851.4
  0.39%0.200.2-10151.6051.651.4
  0.19%0.200.2-20251.5051.551.4
  0.19%0.100.111051.351.3051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
   00000051.6051.651.4
   00000051.751.25251.4
   00000051.651.6051.4
   00000051.651.6051.4
   00000051.952.951.451.4
   00000051.551.5051.4
   00000051.551.5051.4
   00000053.153.1051.4
  -0.10%-0.10-0.122051.551.5051.4
  -0.19%-0.10-0.111051.551.5051.4
  -0.19%-0.10-0.111051.551.5051.4
  -0.19%-0.10-0.1-10151.3051.351.4
  -0.39%-0.20-0.211051.651.6051.4
  -0.39%-0.20-0.211051.651.6051.4
  -0.39%-0.20-0.211051.651.6051.4
  -0.38%-0.2-0.2001152.152.25251.4
  -0.03%-0.20-0.2-1501551.4051.451.4
  -0.15%-0.30.4-0.734151.751.65251.4
  -0.58%-0.30-0.311051.751.7051.4
  -0.65%-0.30-0.311051.851.752.151.4
  -0.39%-0.40-0.422051.651.6051.4
  -0.19%-0.50-0.555051.551.5051.4
  -0.39%-0.60-0.633051.651.6051.4
  -1.15%-0.60-0.61105252051.4
  -1.15%-0.60-0.61105252051.4
  -0.68%-0.70-0.722051.851.8051.4

券商虧損排行 - 2025/03/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.02%-15.90-15.93030051.951.9051.4
  -1.34%-70-71010052.152.1051.4
  -0.68%-2.10-2.166051.851.8051.4
  -0.90%-1.40-1.433051.951.9051.4
  -0.84%-1.30-1.333051.851.8051.4
  -2.10%-1.10-1.111052.552.5051.4
  -2.10%-1.10-1.111052.552.5051.4
  -2.10%-1.10-1.111052.552.5051.4
  -1.91%-10-111052.452.4051.4
  -0.96%-10-122051.951.9051.4
  -0.96%-10-122051.951.9051.4
  -0.44%-0.90-0.944051.651.6051.4
  -1.53%-0.80-0.811052.252.2051.4
  -1.53%-0.80-0.811052.252.2051.4
  -0.77%-0.80-0.822051.851.8051.4
  -0.68%-0.70-0.722051.851.8051.4
  -1.15%-0.60-0.61105252051.4
  -1.15%-0.60-0.61105252051.4
  -0.39%-0.60-0.633051.651.6051.4
  -0.19%-0.50-0.555051.551.5051.4
  -0.39%-0.40-0.422051.651.6051.4
  -0.65%-0.30-0.311051.851.752.151.4
  -0.58%-0.30-0.311051.751.7051.4
  -0.15%-0.30.4-0.734151.751.65251.4
  -0.03%-0.20-0.2-1501551.4051.451.4
  -0.38%-0.2-0.2001152.152.25251.4
  -0.39%-0.20-0.211051.651.6051.4
  -0.39%-0.20-0.211051.651.6051.4
  -0.39%-0.20-0.211051.651.6051.4
  -0.19%-0.10-0.1-10151.3051.351.4
  -0.19%-0.10-0.111051.551.5051.4
  -0.19%-0.10-0.111051.551.5051.4
  -0.10%-0.10-0.122051.551.5051.4
   00000051.551.5051.4
   00000053.153.1051.4
   00000051.651.6051.4
   00000051.952.951.451.4
   00000051.551.5051.4
   00000051.651.6051.4
   00000051.6051.651.4
   00000051.751.25251.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.00%00011051.451.4051.4
  0.19%0.100.111051.351.3051.4
  0.19%0.200.2-20251.5051.551.4
國邑*營運聚焦五大重點 展望正向樂觀Anue鉅亨-5天前
國邑*吸入新藥完成澳洲一期臨床 預計年底完成與美國FDA Pre-IND會議Anue鉅亨-2024/10/23
國邑* 相關文章
國邑* 相關影音